Molecular epidemiology of hepatitis C infection in cyprus: Evidence of polyphyletic infection

Journal of Medical Virology

Volumn 81, Issue 2, 2009, Pages 238-248

  Demetriou, Victoria L ^a   Van De Vijver, David A M C ^b   Kostrikis, Leondios G ^a   Chimonides, S ^c   Evgeniou, Nicosia A ^d   Hadjigeorgiou Vounou, E ^e   Koliou Mazeri, M ^f   Papakyriakou, P ^g   Petsas, L ^h   Potamitis, G ⁱ  

^a UNIVERSITY OF CYPRUS   (Cyprus)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c NICOSIA GENERAL HOSPITAL   (Cyprus)

^d Evgeniou Clinic   (Cyprus)

^e LIMASSOL GENERAL HOSPITAL   (Cyprus)

^f Hospital of Archbishop Makarios III   (Cyprus)

^g Paphos General Hospital   (Cyprus)

^h Larnaca General Hospital   (Cyprus)

ⁱ Gastroenterology Clinic   (Cyprus)

Author keywords

CORE E1 region; HCV genotypes; NS5B region; Phylogenetic analysis

Indexed keywords

INTERFERON; RIBAVIRIN; NS 5 PROTEIN, HEPATITIS C VIRUS; NS-5 PROTEIN, HEPATITIS C VIRUS; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS RNA;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CYPRUS; FEMALE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR EPIDEMIOLOGY; NUCLEOTIDE SEQUENCE; PHYLOGENY; UNINDEXED SEQUENCE; VIRUS STRAIN; ADOLESCENT; CLASSIFICATION; EPIDEMIOLOGY; GENETICS; ISOLATION AND PURIFICATION; MIDDLE AGED; VIROLOGY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CYPRUS; EPIDEMIOLOGY, MOLECULAR; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HUMANS; MALE; MIDDLE AGED; PHYLOGENY; RNA, VIRAL; VIRAL NONSTRUCTURAL PROTEINS; YOUNG ADULT;

HEPATITIS C VIRUS;

EID: 61749087795     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21370     Document Type: Article

References (61)

1. Abdel-Hamid M, El-Daly M, Molnegren V, El-Kafrawy S, Abdel-Latif S, Esmat G, Strickland GT, Loffredo C, Albert J, Widell A. 2007. Genetic diversity in hepatitis C virus in Egypt and possible association with hepatocellular carcinoma. J Gen Virol 88:1526-1531.
2. Altindis M, Yilmaz S, Dikengil T, Acemoglu H, Hosoglu S. 2006. Seroprevalence and genotyping of hepatitis B, hepatitis C and HIV among healthy population and Turkish soldiers in Northern Cyprus. World J Gastroenterol 12:6792-6796.
3. Altuglu I, Soyler I, Ozacar T, Erensoy S. 2007. Distribution of hepatitis C virus genotypes in patients with chronic hepatitis C infection in Western Turkey. Int J Infect Dis 12:239-244.
4. Ansaldi F, Bruzzone B, Salmaso S, Rota MC, Durando P, Gasparini R, Icardi G. 2005. Different seroprevalence and molecular epidemiology patterns of hepatitis C virus infection in Italy. J Med Virol 76:327-332.
5. Antaki N, Haddad M, Kebbewar K, Abdelwahab J, Hamed O, Aaraj R, Alhaj N, Haffar S, Assil M, Ftayeh M, Assaad F, Doghman D, Ali T, Nasserelddine M, Ali A, Antaki F. 2008. The unexpected discovery of a focus of hepatitis C virus genotype 5 in a Syrian province. Epidemiol Infect 17:1-6.
6. Bourliere M, Barberin JM, Rotily M, Guagliardo V, Portal I, Lecomte L, Benali S, Boustiere C, Perrier H, Jullien M, Lambot G, Loyer R, LeBars O, Daniel R, Khiri H, Halfon P. 2002. Epidemiological changes in hepatitis C virus genotypes in France: Evidence in intravenous drug users. J Viral Hepat 9:62-70.
7. Chamberlain RW, Adams NJ, Taylor LA, Simmonds P, Elliott RM. 1997. The complete coding sequence of hepatitis C virus genotype 5a, the predominant genotype in South Africa. Biochem Biophys Res Commun 236:44-49.
8. Chlabicz S, Flisiak R, Kowalczuk O, Wiercinska-Drapalo A, Pytel-Krolczuk B, Prokopowicz D, Chyczewski L. 2008. High prevalence of genotype 4 among hepatitis C virus-infected intravenous drug users in north-eastern Poland. J Med Virol 80:615-618.
9. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. 1989. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244:359-362.
10. Cochrane A, Searle B, Hardie A, Robertson R, Delahooke T, Cameron S, Tedder RS, Dusheiko GM, De Lamballerie X, Simmonds P. 2002. A genetic analysis of hepatitis C virus transmission between injection drug users. J Infect Dis 186:1212-1221.
11. Colina R, Casane D, Vasquez S, Garcia-Aguirre L, Chunga A, Romero H, Khan B, Cristina J. 2004. Evidence of intratypic recombination in natural populations of hepatitis C virus. J Gen Virol 85:31-37.
12. Cristina J, Colina R. 2006. Evidence of structural genomic region recombination in Hepatitis C virus. Virol J 3:53.
13. de Oliveira T, Deforche K, Cassol S, Salminen M, Paraskevis D, Seebregts C, Snoeck J, van Rensburg EJ, Wensing AM, van de Vijver DA, Boucher CA, Camacho R, Vandamme AM. 2005. An automated genotyping system for analysis of HIV-1 and other microbial sequences. Bioinformatics 21:3797-3800.
14. Esteban JI, Sauleda S, Quer J. 2008. The changing epidemiology of hepatitis C virus infection in Europe. J Hepatol 48:148-162.
15. Felsenstein J. 1985. Confidence limits on phylogenies: An approach using the bootstrap. Evolution 39:783-791.
16. Henquell C, Cartau C, Abergel A, Laurichesse H, Regagnon C, De Champs C, Bailly JL, Peigue-Lafeuille H. 2004. High prevalence of hepatitis C virus type 5 in central France evidenced by a prospective study from 1996 to 2002. J Clin Microbiol 42:3030-3035.
17. Huy TT, Abe K. 2004. Molecular epidemiology of hepatitis B and C virus infections in Asia. Pediatr Int 46:223-230.
18. Idrees M. 2008. Development of an improved genotyping assay for the detection of hepatitis C virus genotypes and subtypes in Pakistan. J Virol Methods 150:50-56.
19. Kageyama S, Agdamag DM, Alesna ET, Leano PS, Heredia AM, Abellanosa-Tac-An IP, Jereza LD, Tanimoto T, Yamamura J, Ichimura H. 2006. A natural inter-genotypic (2b/1b) recombinant of hepatitis C virus in the Philippines. J Med Virol 78:1423-1428.
20. Kalinina O, Norder H, Vetrov T, Zhdanov K, Barzunova M, Plotnikova V, Mukomolov S, Magnius LO. 2001. Shift in predominating subtype of HCV from 1b to 3a in St. Petersburg mediated by increase in injecting drug use. J Med Virol 65:517-524.
21. Kalinina O, Norder H, Mukomolov S, Magnius LO. 2002. A natural intergenotypic recombinant of hepatitis C virus identified in St. Petersburg. J Virol 76:4034-4043.
22. Kamal SM, Nasser IA. 2008. Hepatitis C genotype 4: What we know and what we don't yet know. Hepatology 47:1371-1383.
23. Katsoulidou A, Sypsa V, Tassopoulos NC, Boletis J, Karafoulidou A, Ketikoglou I, Tsantoulas D, Vafiadi I, Hatzis G, Skoutelis A, Akriviadis E, Vasiliadis T, Kitis G, Magiorkinis G, Hatzakis A. 2006. Molecular epidemiology of hepatitis C virus (HCV) in Greece: Temporal trends in HCV genotype-specific incidence and molecular characterization of genotype 4 isolates. J Viral Hepat 13:19-27.
24. Kimura M. 1980. A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences. J Mol Evol 16:111-120.
25. Kuiken C, Yusim K, Boykin L, Richardson R. 2005. The Los Alamos hepatitis C sequence database. Bioinformatics 21:379-384.
26. Kurbanov F, Tanaka Y, Sugauchi F, Kato H, Ruzibakiev R, Zalyalieva M, Yunusova Z, Mizokami M. 2003. Hepatitis C virus molecular epidemiology in Uzbekistan. J Med Virol 69:367-375.
27. Kurbanov F, Tanaka Y, Avazova D, Khan A, Sugauchi F, Kan N, Kurbanova-Khudayberganova D, Khikmatullaeva A, Musabaev E, Mizokami M. 2007. Detection of hepatitis C virus natural recombinant RF1-2k/1b strain among intravenous drug users in Uzbekistan. Hepatol Res 38:434-457.
28. Legrand-Abravanel F, Claudinon J, Nicot F, Dubois M, Chapuy-Regaud S, Sandres-Saune K, Pasquier C, Izopet J. 2007. New natural intergenotypic (2/5) recombinant of hepatitis C virus. J Virol 81:4357-4362.
29. McCaw R, Moaven L, Locarnini SA, Bowden DS. 1997. Hepatitis C virus genotypes in Australia. J Viral Hepat 4:351-357.
30. Memon MI, Memon MA. 2002. Hepatitis C: An epidemiological review. J Viral Hepat 9:84-100.
31. Moreau I, Hegarty S, Levis J, Sheehy P, Crosbie O, Kenny-Walsh E, Fanning LJ. 2006. Serendipitous identification of natural inter-genotypic recombinants of hepatitis C in Ireland. Virol J 3:95.
32. Morice Y, Cantaloube JF, Beaucourt S, Barbotte L, De Gendt S, Goncales FL, Butterworth L, Cooksley G, Gish RG, Beaugrand M, Fay F, Fay O, Gonzalez JE, Martins RM, Dhumeaux D, Vanderborght B, Stuyver L, Sablon E, de Lamballerie X, Pawlotsky JM. 2006. Molecular epidemiology of hepatitis C virus subtype 3a in injecting drug users. J Med Virol 78:1296-1303.
33. Murphy DG, Willems B, Deschenes M, Hilzenrat N, Mousseau R, Sabbah S. 2007. Use of sequence analysis of the NS5B region for routine genotyping of hepatitis C virus with reference to C/E1 and 5′ untranslated region sequences. J Clin Microbiol 45:1102-1112.
34. Nakano T, Lu L, Liu P, Pybus OG. 2004. Viral gene sequences reveal the variable history of hepatitis C virus infection among countries. J Infect Dis 190:1098-1108.
35. Naoumov NV. 1999. Hepatitis C virus infection in Eastern Europe. J Hepatol 31(Supp. 1):84-87.
36. Noppornpanth S, Lien TX, Poovorawan Y, Smits SL, Osterhaus AD, Haagmans BL. 2006. Identification of a naturally occurring recombinant genotype 2/6 hepatitis C virus. J Virol 80:7569-7577.
37. Pawlotsky JM, Tsakiris L, Roudot-Thoraval F, Pellet C, Stuyver L, Duval J, Dhumeaux D. 1995. Relationship between hepatitis C virus genotypes and sources of infection in patients with chronic hepatitis C. J Infect Dis 171:1607-1610.
38. Pybus OG, Cochrane A, Holmes EC, Simmonds P. 2005. The hepatitis C virus epidemic among injecting drug users. Infect Genet Evol 5:131-139.
39. Ramia S, Eid-Fares J. 2006. Distribution of hepatitis C virus genotypes in the Middle East. Int J Infect Dis 23:23.
40. Re V, Contigiani M, Yoshida CF, Lampe E. 2007. Identification of hepatitis C virus subtype 2c by sequencing analysis in patients from Cordoba, Argentina. Mem Inst Oswaldo Cruz 102:995-998.
41. Richardson D, Fisher M, Sabin CA. 2008. Sexual transmission of hepatitis C in MSM may not be confined to those with HIV infection. J Infect Dis 197:1213-1214; author reply 1214-1215.
42. Robertson B, Myers G, Howard C, Brettin T, Bukh J, Gaschen B, Gojobori T, Maertens G, Mizokami M, Nainan O, Netesov S, Nishioka K, Shin i T, Simmonds P, Smith D, Stuyver L, Weiner A. 1998. Classification, nomenclature, and database development for hepatitis C virus (HCV) and related viruses: Proposals for standardization. International Committee on Virus Taxonomy. Arch Virol 143:2493-2503.
43. Saitou N, Nei M. 1987. The neighbor-joining method: A new method for reconstructing phylogenetic trees. Mol Biol Evol 4:406-425.
44. Samimi-Rad K, Nategh R, Malekzadeh R, Norder H, Magnius L. 2004. Molecular epidemiology of hepatitis C virus in Iran as reflected by phylogenetic analysis of the NS5B region. J Med Virol 74:246-252.
45. Savvas SP, Koskinas J, Sinani C, Hadziyannis A, Spanou F, Hadziyannis SJ. 2005. Changes in epidemiological patterns of HCV infection and their impact on liver disease over the last 20 years in Greece. J Viral Hepat 12:551-557.
46. Schroter M, Zollner B, Laufs R, Feucht HH. 2004. Changes in the prevalence of hepatitis C virus genotype among injection drug users: A highly dynamic process. J Infect Dis 190:1199-1200; author reply 1200-1201.
47. Seeff LB. 2002. Natural history of chronic hepatitis C. Hepatology 36:S35-S46.
48. Simmonds P. 1999. Viral heterogeneity of the hepatitis C virus. J Hepatol 31(Supp. 1):54-60.
49. Simmonds P, Holmes EC, Cha TA, Chan SW, McOmish F, Irvine B, Beall E, Yap PL, Kolberg J, Urdea MS. 1993. Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol 74:2391-2399.
50. Simmonds P, Bukh J, Combet C, Deleage G, Enomoto N, Feinstone S, Halfon P, Inchauspe G, Kuiken C, Maertens G, Mizokami M, Murphy DG, Okamoto H, Pawlotsky JM, Penin F, Sablon E, Shin IT, Stuyver LJ, Thiel HJ, Viazov S, Weiner AJ, Widell A. 2005. Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 42:962-973.
51. Tallo T, Norder H, Tefanova V, Krispin T, Schmidt J, Ilmoja M, Orgulas K, Pruunsild K, Priimagi L, Magnius LO. 2007. Genetic characterization of hepatitis C virus strains in Estonia: Fluctuations in the predominating subtype with time. J Med Virol 79:374-382.
52. Tamura K, Dudley J, Nei M, Kumar S. 2007. MEGA4: Molecular Evolutionary Genetics Analys (MEGA) software version 4.0. Mol Biol Evol 24:1596-1599.
53. Thompson JD, Gibson TJ, Plewniak F, Jeanmougin F, Higgins DG. 1997. The CLUSTAL-X windows interface: Flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res 25:4876-4882.
54. Trepo C, Pradat P. 1999. Hepatitis C virus infection in Western Europe. J Hepatol 31(Supp. 1):80-83.
55. van Asten L, Verhaest I, Lamzira S, Hernandez-Aguado I, Zangerle R, Boufassa F, Rezza G, Broers B, Robertson JR, Brettle RP, McMenamin J, Prins M, Cochrane A, Simmonds P, Coutinho RA, Bruisten S. 2004. Spread of hepatitis C virus among European injection drug users infected with HIV: A phylogenetic analysis. J Infect Dis 189:292-302.
56. van de Laar TJ, van der Bij AK, Prins M, Bruisten SM, Brinkman K, Ruys TA, van der Meer JT, de Vries HJ, Mulder JW, van Agtmael M, Jurriaans S, Wolthers KC, Coutinho RA. 2007. Increase in HCV incidence among men who have sex with men in Amsterdam most likely caused by sexual transmission. J Infect Dis 196:230-238.
57. Verbeeck J, Maes P, Lemey P, Pybus OG, Wollants E, Song E, Nevens F, Fevery J, Delport W, Van der Merwe S, Van Ranst M. 2006. Investigating the origin and spread of hepatitis C virus genotype 5a. J Virol 80:4220-4226.
58. Watson JP, Al-Mardini H, Awadh S, Ukabam S, Record CO. 1999. Hepatitis C virus genotypes in a cohort of Middle Eastern patients. Ann Saudi Med 19:410-412.
59. WHO. 1999. Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium. J Viral Hepat 6:35-47.
60. Zein NN. 2000. Clinical significance of hepatitis C virus genotypes. Clin Microbiol Rev 13:223-235.
61. Zeuzem S. 2004. Heterogeneous virologic response rates to interferon-based therapy in patients with chronic hepatitis C: Who responds less well? Ann Intern Med 140:370-381.